Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Phaos Technology Holdings (Caym (POAS)
Singapore, SG
Phaos Technology Holdings (Cayman) Limited, operating through its Singapore-based subsidiary Phaos Technology Pte. Ltd., is a company focused on creating and commercializing sophisticated microscopy-related technologies, products, and solutions within Singapore. The company's product portfolio encompasses several specialized offerings: Optonano, which provides users with the ability to view both live and static images, enabling the assembly of high-quality visual data for larger sample regions. PT-Industrial, a versatile tool utilized across various applications including material analysis, fault identification, basic measurement tasks, quality control, inspection, and general manufacturing processes. PT-Metrology, which delivers accurate dimensional measurements through a straightforward, single-button operation. PT-Biology, designed to generate the specific types of imagery required by the biomedical field. PT-Stereo, a stereo microscope that produces crisp, magnified three-dimensional views, especially effective for examining solid or thicker samples. And PT-Zoom, which enhances visual understanding by providing a magnified 3D perspective of specimens. Beyond its hardware, the firm also furnishes specialized software. Its diverse clientele includes manufacturing enterprises, healthcare service providers in the biomedical sector, and various research and development organizations. Phaos Technology Holdings was founded in 2017 and maintains its corporate headquarters in Singapore.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.99% | +12.73% | -87.59% | -78.13% | -91.43% | -90.63% | -91.65% | -91.65% | -91.65% | -91.65% | -91.65% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Medical - Devices: +11.2%-91.1%
-
EPS growth Medical - Devices: +28.5%-116.7%
-
FCF margin FCF growth · Medical - Devices: +30.9%-3,104.6%
-
EBIT margin Medical - Devices: +6.2%-3,058.1%
-
ROIC Medical - Devices: +3.3%—
-
Share dilution Medical - Devices: 0.0%+0.0% ★
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×-0.05×
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings history not available.
Ownership Overview
No beneficial ownership filings recorded.
Institutional Activity (13F)
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | XTX TOPCO LTD | 153.1K +153.1K (+100.0%) | 246.5K +246.5K (+100.0%) | 1.15% +1.151 pp | 0.00% +0.004 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 2 | HRT FINANCIAL LP | 119.2K +70.9K (+146.5%) | 191.0K +26.0K (+15.8%) | 0.90% +0.533 pp | 0.00% +0.000 pp | USD2.35 -31.5% | 2 qtrs — |
| 3 | UBS GROUP AG | 22.6K -2.1K (-8.5%) | 36.5K -48.4K (-57.0%) | 0.17% -0.016 pp | 0.00% +0.000 pp | USD3.43 -53.1% | 2 qtrs — |
| 4 | RENAISSANCE TECHNOLOGIES LLC | 14.1K +14.1K (+100.0%) | 22.7K +22.7K (+100.0%) | 0.11% +0.106 pp | 0.00% +0.000 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 5 | CITADEL ADVISORS LLC | — -78.9K (-100.0%) | — -270.7K (-100.0%) | 0.00% -0.593 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 6 | MAREX GROUP PLC | — -31.2K (-100.0%) | — -107.2K (-100.0%) | 0.00% -0.235 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Hong Loon Gan | Interim CEO, CFO & Executive Director | — | male |
| Hook Seng Beh | Executive Chairman | — | male |
| Minghui Hong | Chief Technology Advisor | — | — |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for POAS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
